Operating
Contingent consideration fair value adjustments
Cencora Contingent consideration fair value adjustments increased by 31.6% to $55.45M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 48.0%, from $37.46M to $55.45M.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ3 2024
Last reportedQ2 2026May 6, 2026
How to read this metric
Increases often signal that acquired assets are performing better than expected, requiring higher future payouts, while decreases may suggest lower-than-anticipated success in R&D milestones.
Detailed definition
This reflects the periodic adjustments to the fair value of earn-out provisions or milestone payments related to past bu...
Peer comparison
Standard for R&D-heavy firms that frequently acquire biotech companies with milestone-based deal structures.
Metric ID:
operating_business_combination_contingent_consideration__7f0be7Historical Data
6 periods
| Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $37.46M | $37.46M | $42.14M | $55.45M |
| QoQ Change | — | — | — | +0.0% | +12.5% | +31.6% |
| YoY Change | — | — | — | — | — | +48.0% |
Range$0.00 – $55.45M
Avg YoY Growth+48.0%
Median YoY Growth+48.0%
Current Streak3+ quarters growth
Contingent consideration fair value adjustments at Other Companies
Frequently Asked Questions
- What is Cencora's contingent consideration fair value adjustments?
- Cencora (COR) reported contingent consideration fair value adjustments of $55.45M in Q1 2026.
- How has Cencora's contingent consideration fair value adjustments changed year-over-year?
- Cencora's contingent consideration fair value adjustments increased by 48.0% year-over-year, from $37.46M to $55.45M.
- What does contingent consideration fair value adjustments mean?
- Changes in the estimated cost of future payments owed to sellers of acquired companies based on performance milestones.